Key Events This Week
16 Feb: Stock opens at Rs.260.47, surging 7.44%
17 Feb: New 52-week and all-time high of Rs.1435 reached
18 Feb: Hits new 52-week high of Rs.1460 amid volatile trading
20 Feb: New 52-week and all-time high of Rs.312.4 with 17.15% daily gain
20 Feb: Week closes at Rs.297.75, up 22.82% for the week
16 February 2026: Strong Opening with 7.44% Gain
Titan Biotech Ltd began the week on a bullish note, closing at Rs.260.47, a 7.44% increase from the previous Friday’s close of Rs.242.43. This gain significantly outpaced the Sensex’s 0.70% rise to 36,787.89. The volume of 33,918 shares indicated healthy investor participation, setting the tone for the week’s momentum.
17 February 2026: New 52-Week and All-Time High of Rs.1435
The stock surged further on 17 February, hitting a new 52-week and all-time high of Rs.1435. It opened with a gap up of 7.5% and closed with a 9.38% daily gain at Rs.284.90, outperforming the Sensex’s modest 0.32% increase. This marked the seventh consecutive day of gains, delivering a cumulative return of 38.53% over that period. The strong financial results released recently, including a 107.11% net profit growth in the December 2025 quarter and record quarterly sales of Rs.56.51 crores, underpinned this rally. The stock’s technical position remained robust, trading above all key moving averages.
18 February 2026: Volatile Session Despite New High of Rs.1460
On 18 February, Titan Biotech reached another new 52-week and all-time high of Rs.1460. However, the day was marked by significant volatility, with the stock swinging between an intraday high of Rs.1460 and a low of Rs.1212.20, a 14.9% intraday range. Despite this, the stock closed at Rs.258.94, down 9.11% for the day, underperforming the Sensex’s 0.43% gain. This pullback followed a strong rally and may reflect short-term profit-taking. The company’s financial strength and low debt-to-equity ratio of 0.04 times continued to support investor confidence.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
19 February 2026: Modest Recovery Amid Market Weakness
The stock rebounded slightly on 19 February, gaining 0.54% to close at Rs.260.34 despite the Sensex declining 1.45% to 36,523.88. The volume dropped to 27,561 shares, indicating a cautious market environment. Titan Biotech’s ability to hold ground amid broader market weakness highlighted its relative resilience and underlying strength.
20 February 2026: New 52-Week High of Rs.312.4 with 17.15% Gain
Closing the week on a high note, Titan Biotech surged 17.15% to Rs.297.75, reaching a new 52-week and all-time high intraday price of Rs.312.4. The stock opened with a 10.76% gap up and exhibited a 7.34% intraday volatility, reflecting strong trading interest. This two-day rally delivered a cumulative return of 20.65%. The stock outperformed the specialty chemicals sector by 19.83% and the Sensex by 0.41%. Despite the recent gains, the stock remained below its longer-term moving averages, suggesting the rally may be a sharp short-term move within a broader range.
Curious about Titan Biotech Ltd from ? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!
- - Detailed research coverage
- - Technical + fundamental view
- - Decision-ready insights
Daily Price Comparison: Titan Biotech Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-16 | Rs.260.47 | +7.44% | 36,787.89 | +0.70% |
| 2026-02-17 | Rs.284.90 | +9.38% | 36,904.38 | +0.32% |
| 2026-02-18 | Rs.258.94 | -9.11% | 37,062.35 | +0.43% |
| 2026-02-19 | Rs.260.34 | +0.54% | 36,523.88 | -1.45% |
| 2026-02-20 | Rs.297.75 | +14.37% | 36,674.32 | +0.41% |
Key Takeaways
Robust Weekly Gains: Titan Biotech Ltd’s 22.82% weekly gain dwarfed the Sensex’s 0.39%, highlighting exceptional relative strength.
Multiple New Highs: The stock set new 52-week and all-time highs on 17, 18, and 20 February, reflecting sustained bullish momentum.
Strong Financials: Record quarterly results with 107.11% net profit growth and highest-ever sales and PBDIT underpin the rally.
Volatility and Profit-Taking: The sharp pullback on 18 February amid high intraday volatility suggests short-term profit-taking after a strong run.
Conservative Capital Structure: Low debt-to-equity ratio of 0.04 times supports financial stability and investor confidence.
Premium Valuation: Elevated price-to-book and PEG ratios indicate the stock trades at a premium, reflecting high growth expectations.
Conclusion
Titan Biotech Ltd’s performance during the week of 16–20 February 2026 was characterised by strong price appreciation, multiple record highs, and robust financial results. The stock’s 22.82% gain significantly outpaced the Sensex, driven by impressive quarterly earnings growth and sustained technical strength. While the midweek volatility and pullback highlight some short-term caution, the overall trend remains positive, supported by a conservative capital structure and upgraded mojo rating. Investors should note the premium valuation levels, which reflect high expectations for continued growth within the specialty chemicals sector. This week’s developments reinforce Titan Biotech Ltd’s position as a standout performer in the market.
Limited Period Only. Start at Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Get 71% Off →
